145 related articles for article (PubMed ID: 30043122)
1. Development of an Algorithm to Identify Cannabis Urine Drug Test Results within a Multi-Site Electronic Health Record System.
Morasco BJ; Shull SE; Adams MH; Dobscha SK; Lovejoy TI
J Med Syst; 2018 Jul; 42(9):163. PubMed ID: 30043122
[TBL] [Abstract][Full Text] [Related]
2. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
[TBL] [Abstract][Full Text] [Related]
3. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
[TBL] [Abstract][Full Text] [Related]
4. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
[TBL] [Abstract][Full Text] [Related]
5. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
[TBL] [Abstract][Full Text] [Related]
6. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.
Zaman T; Bravata DM; Byers AL; Krebs EE; Leonard SJ; Sandbrink F; Barker W; Keyhani S
BMC Psychiatry; 2023 Mar; 23(1):177. PubMed ID: 36927526
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
8. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
[TBL] [Abstract][Full Text] [Related]
9. Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.
Andraka-Christou B; McAvoy E; Gordon AJ; Ohama M; Brach M; Taylor EA; Vaiana M; Saloner B; Stein BD
Pain Med; 2023 Dec; 24(12):1306-1317. PubMed ID: 37551941
[TBL] [Abstract][Full Text] [Related]
10. Urine drug testing: current recommendations and best practices.
Owen GT; Burton AW; Schade CM; Passik S
Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
[TBL] [Abstract][Full Text] [Related]
11. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.
Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI
J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754
[TBL] [Abstract][Full Text] [Related]
12. Random urine drug testing among patients receiving opioid therapy for cancer pain.
Arthur JA; Tang M; Lu Z; Hui D; Nguyen K; Rodriguez EM; Edwards T; Yennurajalingam S; Dalal S; Dev R; Reddy A; Tanco K; Haider A; Liu DD; Bruera E
Cancer; 2021 Mar; 127(6):968-975. PubMed ID: 33231885
[TBL] [Abstract][Full Text] [Related]
13. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing.
Matteliano D; Chang YP
Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349
[TBL] [Abstract][Full Text] [Related]
14. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
[TBL] [Abstract][Full Text] [Related]
15. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
[TBL] [Abstract][Full Text] [Related]
17. The presence of microscopic hematuria detected by urine dipstick test in the evaluation of patients with renal colic.
Argyropoulos A; Farmakis A; Doumas K; Lykourinas M
Urol Res; 2004 Aug; 32(4):294-7. PubMed ID: 15045479
[TBL] [Abstract][Full Text] [Related]
18. Urine drug test interpretation: what do physicians know?
Reisfield GM; Bertholf R; Barkin RL; Webb F; Wilson G
J Opioid Manag; 2007; 3(2):80-6. PubMed ID: 17520987
[TBL] [Abstract][Full Text] [Related]
19. Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects.
Lee CT; Vo TT; Cohen AS; Ahmed S; Zhang Y; Mao J; Chen L
Pain Med; 2016 Apr; 17(4):636-43. PubMed ID: 26398237
[TBL] [Abstract][Full Text] [Related]
20. Repeated Quantitative Urine Toxicology Analysis May Improve Chronic Pain Patient Compliance with Opioid Therapy.
Knezevic NN; Khan OM; Beiranvand A; Candido KD
Pain Physician; 2017 Feb; 20(2S):S135-S145. PubMed ID: 28226335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
